Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $1.63 Million - $1.93 Million
85,358 New
85,358 $1.67 Million
Q4 2023

Feb 09, 2024

BUY
$23.64 - $30.27 $4.17 Million - $5.34 Million
176,510 New
176,510 $5.1 Million
Q3 2023

Nov 13, 2024

BUY
$26.74 - $40.81 $5.56 Million - $8.48 Million
207,810 New
207,810 $5.56 Million
Q3 2023

Nov 13, 2023

SELL
$26.74 - $40.81 $1.46 Million - $2.23 Million
-54,687 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$28.52 - $40.7 $1.3 Million - $1.85 Million
45,452 Added 53.25%
130,810 $4.84 Million
Q2 2023

Aug 14, 2023

SELL
$28.52 - $40.7 $2.52 Million - $3.6 Million
-88,392 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$29.39 - $36.27 $3.11 Million - $3.83 Million
105,710 New
105,710 $3.3 Million
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $2.1 Million - $2.9 Million
71,887 New
71,887 $2.14 Million
Q3 2022

Nov 13, 2023

BUY
$37.92 - $63.74 $2.07 Million - $3.49 Million
54,687 New
54,687 $2.08 Million
Q2 2022

Aug 14, 2023

BUY
$47.98 - $62.75 $4.24 Million - $5.55 Million
88,392 New
88,392 $4.82 Million
Q1 2022

May 12, 2023

BUY
$49.85 - $96.11 $3.07 Million - $5.92 Million
61,612 Added 85.71%
133,499 $8.33 Million
Q1 2022

May 09, 2022

SELL
$49.85 - $96.11 $6.65 Million - $12.8 Million
-133,499 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$77.3 - $105.0 $10.3 Million - $14 Million
133,499 New
133,499 $13.4 Million
Q3 2021

Nov 14, 2022

BUY
$74.87 - $110.87 $8.06 Million - $11.9 Million
107,605 New
107,605 $9.68 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.